A new antifibrotic target of Ac-SDKP: inhibition of myofibroblast differentiation in rat lung with silicosis
about
N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetesFragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitorsMolecular mechanisms of pulmonary response progression in crystalline silica exposed ratsGenome-wide DNA methylation analysis in lung fibroblasts co-cultured with silica-exposed alveolar macrophages.Acetylated α-Tubulin Regulated by N-Acetyl-Seryl-Aspartyl-Lysyl-Proline(Ac-SDKP) Exerts the Anti-fibrotic Effect in Rat Lung Fibrosis Induced by SilicaThe anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase.Dibutyryl-cAMP attenuates pulmonary fibrosis by blocking myofibroblast differentiation via PKA/CREB/CBP signaling in rats with silicosis.Antifibrotic peptide N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP): opportunities for angiotensin-converting enzyme inhibitor design.The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis.FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway.The influence of angiotensin converting enzyme mutations on the kinetics and dynamics of N-domain selective inhibition.Angiotensin-converting enzyme defines matrikine-regulated inflammation and fibrosis.Pulmonary toxicity and global gene expression changes in response to sub-chronic inhalation exposure to crystalline silica in rats.Prolyl oligopeptidase inhibitor suppresses the upregulation of ACSDKP in patients with acute myeloid leukemia.Influence of the interaction between Ac‑SDKP and Ang II on the pathogenesis and development of silicotic fibrosis.
P2860
Q27008887-9C07E3A5-1001-44F9-96D7-22A139629C8EQ27679900-401D2D48-661D-41E8-9775-2D76523ABE0FQ29417860-1E55E423-0B7A-4440-8CC7-F8468C617B0FQ33677179-89F67040-52ED-46E9-849D-A1384A5E5906Q36117802-A2157806-B7C8-4F63-B56E-F299B5091445Q36957095-39C8AD52-2CC3-4961-8DA1-624F8C9E0844Q37658195-D95BA863-466D-4F0D-B963-4EDE8E93AEFFQ38076770-7D5A778E-E907-48D6-9FF7-8089220188ACQ38224257-59AB2DD8-E194-480D-AA11-C3A07143F1C5Q38644648-53F906AE-4CFB-4C4A-89C2-E513335E5CF3Q38820520-0ED02352-CB5A-42D5-8121-8A34952D979AQ46248584-EF030B92-C417-4DF1-89AA-A0C1785CCD6BQ49817801-E216A571-0501-4CDA-B187-CF4999FA913CQ55196338-DFF21760-FE94-41AE-9DD5-669ED4A4707BQ55451084-8010207A-A7AC-4B4D-9295-9CB9988338E5
P2860
A new antifibrotic target of Ac-SDKP: inhibition of myofibroblast differentiation in rat lung with silicosis
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A new antifibrotic target of A ...... ion in rat lung with silicosis
@ast
A new antifibrotic target of A ...... ion in rat lung with silicosis
@en
A new antifibrotic target of A ...... ion in rat lung with silicosis
@nl
type
label
A new antifibrotic target of A ...... ion in rat lung with silicosis
@ast
A new antifibrotic target of A ...... ion in rat lung with silicosis
@en
A new antifibrotic target of A ...... ion in rat lung with silicosis
@nl
prefLabel
A new antifibrotic target of A ...... ion in rat lung with silicosis
@ast
A new antifibrotic target of A ...... ion in rat lung with silicosis
@en
A new antifibrotic target of A ...... ion in rat lung with silicosis
@nl
P2093
P2860
P3181
P1433
P1476
A new antifibrotic target of A ...... ion in rat lung with silicosis
@en
P2093
Darrell Brann
Ruimin Wang
Zhongqiu Wei
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0040301
P407
P577
2012-01-01T00:00:00Z